Crossmark

Detection of SARS-CoV-2 from patient fecal samples by whole genome sequencing

Published Online: 2021-01-30

Published Print: 2021-12

Authors

Papoutsis, Andreas http://orcid.org/0000-0002-7035-5101
Borody, Thomas

Dolai, Siba

Daniels, Jordan

Steinberg, Skylar

Barrows, Brad

Hazan, Sabine
Clinical Trials ^BETA

Clinical trials referenced in this document:

nct04359836 at ClinicalTrials.gov

Documents that mention this clinical trial

Detection of SARS-CoV-2 from patient fecal samples by whole genome sequencing
https://doi.org/10.1186/s13099-021-00398-5
License Information

Text and Data Mining valid from 2021-01-30

Version of Record valid from 2021-01-30
More Information

Article History

Received: 24 July 2020

Accepted: 12 January 2021

First Online: 30 January 2021

Ethics approval and consent to participate

: This study was approved by the institutional review board of Advarra. Consent to participate in this study from each patient was agreed via signed informed consent.

: Agreed to by patients on the signed informed consent, demonstrating that the patient understood the procedures and the purpose of the study.

: The authors declare that they have no competing interests.

Document is current